Cargando…
How the Discovery of the CD4/CD8-p56(lck) Complexes Changed Immunology and Immunotherapy
The past 25 years have seen enormous progress in uncovering the receptors and signaling mechanisms on T-cells that activate their various effecter functions. Until the late 1980s, most studies on T-cells had focused on the influx of calcium and the levels of cAMP/GMP in T-cells. My laboratory then u...
Autor principal: | Rudd, Christopher E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005572/ https://www.ncbi.nlm.nih.gov/pubmed/33791292 http://dx.doi.org/10.3389/fcell.2021.626095 |
Ejemplares similares
-
LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients
por: Zheng, Xiaonan, et al.
Publicado: (2021) -
Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck
Publicado: (1990) -
CD8β Endows CD8 with Efficient Coreceptor Function by Coupling T Cell Receptor/CD3 to Raft-associated CD8/p56(lck) Complexes
por: Arcaro, Alexandre, et al.
Publicado: (2001) -
CD226: An Emerging Role in Immunologic Diseases
por: Huang, Zhiyi, et al.
Publicado: (2020) -
The Interplay Between Epigenetic Regulation and CD8(+) T Cell Differentiation/Exhaustion for T Cell Immunotherapy
por: Wong, Wai Ki, et al.
Publicado: (2022)